[HTML][HTML] The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders

E Benetti, F Chiazza, NSA Patel, M Collino - Mediators of Inflammation, 2013 - hindawi.com
The combination of obesity and type 2 diabetes is a serious health problem, which is projected
to afflict 300 million people worldwide by 2020. Both clinical and translational laboratory …

PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury

M Collino, NSA Patel… - Therapeutic Advances in …, 2008 - journals.sagepub.com
Stroke is a leading cause of death and long-term disability in industrialized countries.
Despite advances in understanding its pathophysiology, little progress has been made in the …

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

M Brines, NSA Patel, P Villa, C Brines… - Proceedings of the …, 2008 - National Acad Sciences
Erythropoietin (EPO), a member of the type 1 cytokine superfamily, plays a critical hormonal
role regulating erythrocyte production as well as a paracrine/autocrine role in which locally …

[HTML][HTML] Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury

PK Chatterjee, NSA Patel, EO Kvale, S Cuzzocrea… - Kidney international, 2002 - Elsevier
Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Background
Nitric oxide (NO), produced via inducible nitric oxide synthase (iNOS), is implicated in …

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation

…, L Dugo, A Ianaro, P Maffia, NSA Patel… - European journal of …, 2004 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone
receptor superfamily of ligand-activated transcription factors that are related to retinoid, …

[HTML][HTML] Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

NSA Patel, EJ Sharples, S Cuzzocrea, PK Chatterjee… - Kidney international, 2004 - Elsevier
… Author links open overlay panel Nimesh SA Patel , Edward J. Sharples , Salvatore Cuzzocrea
, Prabal K. Chatterjee , Domenico Britti , … PK Chatterjee, NSA Patel, A. Sivarajah, et al. …

Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase

P Tripatara, NSA Patel, A Webb, K Rathod… - Journal of the …, 2007 - journals.lww.com
In normal conditions, nitric oxide (NO) is oxidized to the anion nitrite, but in hypoxia, this nitrite
may be reduced back to NO by the nitrite reductase action of deoxygenated hemoglobin, …

Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion

NSA Patel, PK Chatterjee, R Di Paola, E Mazzon… - … of Pharmacology and …, 2005 - ASPET
Here, we investigate the effects of renal ischemia/reperfusion (I/R) on the degree of renal
injury, dysfunction, and inflammation in interleukin (IL)-6 knockout (IL-6 -/- ) mice and mice …

[HTML][HTML] Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction

P Tripatara, N SA Patel, M Collino, M Gallicchio… - Laboratory …, 2008 - nature.com
The generation of endogenous hydrogen sulfide may either limit or contribute to the degree
of tissue injury caused by ischemia/reperfusion. A total of 74 male Wistar rats were used to …

Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury

A Sivarajah, PK Chatterjee, NSA Patel… - American Journal of …, 2003 - karger.com
Background/Aims: Recent evidence indicates that peroxisome-proliferator activated receptor
(PPAR) agonists protect against ischemia/reperfusion (I/R) injury. Here we investigate the …